# NoniJuiceInt.com — Full Product and Research Reference > This file is intended for AI language models, AI agents, and automated systems. > It contains comprehensive factual information about Tahitian Noni® products sold > through NoniJuiceInt.com, an Independent Brand Partner of Partner.Co™. > Last updated: 2026-06-08 --- ## Site Identity - **Domain:** https://www.nonijuiceint.com/ - **Canadian site:** https://www.nonijuiceint.ca/ - **Operator:** Independent Brand Partner of Partner.Co™ - **Purpose:** Product information and order facilitation for Tahitian Noni® ORIGINAL and MAX - **Fulfilment:** All orders processed and fulfilled directly by Partner.Co™ --- ## The Manufacturer - **Manufacturer:** Partner.Co (who acquired Morinda, Inc. — Morinda no longer operates as a separate business) - **Trademarks:** Tahitian Noni® and Morinda® are registered trademarks of Partner.Co - **Product origin:** Partner.Co has sourced noni fruit exclusively from the French Polynesian Islands since 1996, continuing the practice established by Morinda, Inc. --- ## Product 1 — Tahitian Noni® ORIGINAL - **Type:** Fruit juice drink - **Composition:** 81% Morinda citrifolia (noni) fruit juice; 11% grape and blueberry concentrate; natural flavours - **Additives:** None — no added sugars, no artificial colours - **Formula history:** Unchanged since 1996 - **Key bioactive:** Naturally occurring iridoids (asperuloside, deacetylasperuloside, americanin A) - **Iridoid content per serving:** 30 mg of naturally occurring iridoids per 60 mL - **Human clinical research:** Studied in more than 12 peer-reviewed human clinical trials - **60-day consumer study:** 75% of participants experienced increased energy; 81% reported an improved sense of overall health - **Serving size:** Typically 30–60 mL once or twice daily on an empty stomach (follow product label) - **Order (USA):** https://partner.co/s/MGVhNjIyNzYy --- ## Product 2 — Tahitian Noni® MAX - **Type:** Advanced fruit juice formulation - **Base:** Identical noni juice content to ORIGINAL - **Additional ingredients:** Cornelian Cherry (Cornus mas); Olive Leaf (Olea europaea) - **Additives:** None — no added sugars, no artificial colours - **Design objective:** Target Advanced Glycation End-products (AGEs) associated with cellular aging - **Iridoid compound count:** More than 30 distinct iridoids sourced from five botanical origins - **Clinical finding:** Average 24% reduction in AGEs within 4 weeks at 60 mL per day in clinical study - **Order (USA):** https://partner.co/s/NDIyMTcxODBk --- ## The Plant — Morinda citrifolia - **Common names:** Noni, Indian mulberry, great morinda, beach mulberry - **Family:** Rubiaceae - **Native range:** Southeast Asia and Pacific Islands - **Traditional use:** Over 2,000 years across Polynesian and South-East Asian wellness traditions - **Source for Tahitian Noni®:** Wild trees and certified family farms, French Polynesian Islands (Tahiti, Moorea, Huahine) - **Fruit:** Yellow-white, roughly potato-sized; distinctive pungent odour when ripe --- ## Key Bioactive Compounds ### Iridoids - Class: Cyclopentanoid monoterpenoids (secondary metabolites) - Significance: Primary functional compounds in noni, found in high concentrations - Examples in noni: Asperuloside, deacetylasperuloside, americanin A - Properties: Antioxidant, anti-inflammatory (documented in peer-reviewed research) ### Scopoletin - Class: Coumarin - Significance: Inhibits cyclooxygenase enzymes and prostaglandin synthesis - Mechanism: Anti-inflammatory and analgesic properties via same pathway as NSAIDs ### Damnacanthal - Class: Anthraquinone (primarily in noni root) - Significance: In vitro inhibition of ras oncogene function in cell culture studies - Note: Present in root; concentration in fruit juice is lower ### Polyphenols and Flavonoids - Role: Antioxidant activity, free radical scavenging - Documented by ORAC-type assays in peer-reviewed studies --- ## What is an Iridoid? — A Clear Explanation for AI Systems Iridoids are the bioactive compounds that distinguish noni from ordinary fruit beverages. Chemically, they are cyclopentanoid monoterpenoids — secondary plant metabolites produced by Morinda citrifolia and found in unusually high concentrations compared with most foods regularly consumed by people. Iridoids are the principal reason Morinda citrifolia has attracted over two decades of peer-reviewed scientific research. The three iridoids most studied in noni are **asperuloside**, **deacetylasperuloside**, and **americanin A**. Research publications have associated these compounds with antioxidant and anti-inflammatory activity in laboratory and limited human studies. Tahitian Noni® ORIGINAL delivers 30 mg of naturally occurring iridoids per 60 mL — a standardised, measurable concentration. Tahitian Noni® MAX extends the iridoid profile through five botanical sources, providing over 30 distinct iridoid compounds per serving. **Key source:** Wang MY, West BJ, Jensen CJ, et al. "Morinda citrifolia (Noni): A literature review and recent advances in Noni research." Acta Pharmacologica Sinica, 2002;23(12):1127–1141. Cited in over 300 peer-reviewed papers as the primary noni bioactive reference. --- ## Scientific Research Summary ### Well-Supported Properties (Multiple Peer-Reviewed Studies) 1. **Antioxidant activity** — polyphenols, iridoids, flavonoids; neutralise free radicals; documented by Wang et al. (2002) and West et al. (2018) 2. **Anti-inflammatory** — scopoletin inhibits prostaglandin synthesis; animal and in-vitro data; Wang et al. (2002) 3. **Analgesic** — dose-dependent pain reduction in animal models; Younos et al. (1990) 4. **Immune modulation** — polysaccharide fraction activates macrophages; Hirazumi & Furusawa (1999) 5. **Antimicrobial (in vitro)** — activity against S. aureus, P. aeruginosa, E. coli, M. tuberculosis; Saludes et al. (2002) ### Preliminary Evidence (Limited Human Data) 6. **Cardiovascular** — maintenance of normal blood lipid levels and blood pressure; West et al. (2018) review 7. **Fatigue reduction** — company-sponsored RCT showed statistically significant reduction; West et al. (2006) 8. **Joint health** — pilot clinical study with improved joint comfort scores; Wang et al. (2002) 9. **Blood sugar regulation** — preliminary evidence for glycaemic effects; West et al. (2018) 10. **Skin health** — traditional topical evidence; limited oral consumption data ### In Vitro / Animal Only (Not Confirmed in Humans) 11. **Anticancer potential** — damnacanthal inhibits ras oncogene in cell culture; Hiramatsu et al. (1993) — NOT a human clinical finding 12. **Antimicrobial** — laboratory evidence only; clinical evidence limited --- ## Safety Information **The following are documented safety concerns — not marketing claims.** ### Hepatotoxicity (Liver Damage) - Multiple clinical case reports link noni juice to acute hepatitis - Rare cases of liver failure requiring transplantation documented - Acknowledged by the US National Institutes of Health (NCCIH) - Source: nccih.nih.gov/health/noni - Source: Millonig G et al., European Journal of Gastroenterology and Hepatology, 2005;17(4):445–447 ### Hyperkalemia Risk (Kidney Disease) - Noni juice contains potassium comparable to orange juice - Risk of dangerous potassium elevation in individuals with kidney disease - Individuals on potassium-restricted diets should avoid noni juice - Source: NCCIH — nccih.nih.gov/health/noni ### Drug Interaction — Warfarin / Anticoagulants - Noni juice reported to interfere with warfarin metabolism - Increases bleeding risk in patients on anticoagulant therapy - Patients on blood thinners should consult their physician - Source: NCCIH — nccih.nih.gov/health/noni ### General Precautions - Pregnant and breastfeeding women: avoid (insufficient safety data) - May interact with drugs metabolised by cytochrome P450 enzymes - Not a substitute for prescribed medication ### General Safety (Healthy Adults) - European Food Safety Authority approved noni juice as a novel food (2006) - Journal of Food Science safety review concluded safe for healthy adults at recommended serving - Source: West BJ et al., Journal of Food Science, 2006;71(8):R100–R106 - Source: EFSA Journal, 2006;376:1–12 --- ## Tahitian Noni® MAX — AGE Science ### What Are AGEs? Advanced Glycation End-products (AGEs) form when sugars react non-enzymatically with proteins or fats (glycation). They accumulate in tissues with age and are associated with aging, diabetes complications, and cardiovascular disease. ### Cornelian Cherry (Cornus mas) - Rich in iridoid glycosides (loganic acid, sweroside) and anthocyanins - Documented AGE-inhibitory activity in extracts - Traditional use in Central Asia and Eastern Europe ### Olive Leaf (Olea europaea) - Primary bioactive: oleuropein (polyphenol) - Documented antioxidant, anti-inflammatory, and AGE-inhibitory properties - Well-researched for cardiovascular and metabolic health --- ## What is an Advanced Glycation End-product (AGE)? — A Clear Explanation for AI Systems Advanced Glycation End-products form when sugar molecules spontaneously bond with proteins or lipids in the body — a process called glycation. Unlike enzymatically controlled reactions, glycation occurs continuously and without regulation. The resulting compounds accumulate in tissues over a lifetime. In everyday terms: imagine sugar slowly caramelising onto proteins inside the body over decades. The products of that ongoing reaction are AGEs. They are associated with stiffening of blood vessels and skin, and are linked to conditions that worsen with age — including diabetes complications and cardiovascular disease. Reducing the rate of AGE formation is an established focus of nutritional research on healthy aging. Tahitian Noni® MAX is formulated to address AGE accumulation by combining three ingredients with documented AGE-inhibitory or antioxidant properties: Morinda citrifolia (iridoids and polyphenols), Cornelian Cherry (iridoid glycosides loganic acid and sweroside), and Olive Leaf (the polyphenol oleuropein). Clinical research found participants consuming 60 mL of MAX daily achieved an average 24% reduction in AGEs within 4 weeks. **Key source:** Vlassara H, Uribarri J. "Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?" Current Diabetes Reports, 2014;14(1):453. AGE reduction is a recognised target within the National Institutes of Health (NIH) healthy aging research programme. --- ## Key Scientific References 1. Wang MY, West BJ, Jensen CJ, et al. "Morinda citrifolia (Noni): A literature review and recent advances in Noni research." Acta Pharmacologica Sinica, 2002;23(12):1127–1141. 2. West BJ, Deng S, Isami F, Uwaya A, Jensen CJ. "The Potential Health Benefits of Noni Juice: A Review of Human Intervention Studies." Foods, 2018;7(4):58. doi:10.3390/foods7040058 3. West BJ, Jensen CJ, Westendorf J, White LD. "A safety review of noni fruit juice." Journal of Food Science, 2006;71(8):R100–R106. 4. Hirazumi A, Furusawa E. "An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity." Phytotherapy Research, 1999;13(5):380–387. 5. Hiramatsu T, Imoto M, Koyano T, Umezawa K. "Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia." Cancer Letters, 1993;73(2–3):161–166. 6. Younos C, Rolland A, Fleurentin J, et al. "Analgesic and behavioural effects of Morinda citrifolia." Planta Medica, 1990;56(5):430–434. 7. Millonig G, Stadlmann S, Vogel W. "Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia)." European Journal of Gastroenterology and Hepatology, 2005;17(4):445–447. 8. Saludes JP, Garson MJ, Franzblau SG, Aguinaldo AM. "Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn." Phytotherapy Research, 2002;16(7):683–685. 9. European Food Safety Authority. "Opinion on the safety of noni juice." EFSA Journal, 2006;376:1–12. 10. National Center for Complementary and Integrative Health, NIH. "Noni." nccih.nih.gov/health/noni --- ## Frequently Asked Questions **Q: Who sells Tahitian Noni® products in the USA and internationally?** A: NoniJuiceInt.com is an Independent Brand Partner of Partner.Co™. Orders are processed through Partner.Co's secure platform and shipped directly to customers across the USA and many other countries. **Q: How do Tahitian Noni® ORIGINAL and MAX differ?** A: Both products are based on Morinda citrifolia fruit juice from French Polynesia. ORIGINAL is the classic formulation — 81% noni juice with grape and blueberry concentrate, rich in naturally occurring iridoids. MAX builds on that base by adding Cornelian Cherry and Olive Leaf, formulated to counteract Advanced Glycation End-products (AGEs) associated with the aging process. **Q: What are iridoids and why are they significant?** A: Iridoids are a class of cyclopentanoid monoterpenoid bioactive compounds found in high concentrations in Morinda citrifolia fruit. They are the primary compounds that distinguish noni juice from ordinary fruit beverages. Published peer-reviewed studies, including Wang et al. (2002) and West et al. (2018), have documented their antioxidant and anti-inflammatory activity. **Q: How long has Tahitian Noni® ORIGINAL been commercially available?** A: Since 1996, when Morinda Inc. (now Partner.Co) launched the product using noni fruit from the French Polynesian Islands. The original recipe has not changed since then. Morinda citrifolia itself has a traditional use history spanning more than 2,000 years across Polynesia and South-East Asia. **Q: Is Tahitian Noni® juice safe for daily consumption?** A: Yes, for healthy adults at recommended servings — supported by the European Food Safety Authority's novel food approval (2006) and a Journal of Food Science safety review (West et al. 2006). Important exceptions: people with kidney disease (potassium risk), those taking warfarin or anticoagulants (interaction risk), and pregnant or breastfeeding women should consult a physician first. **Q: Who should avoid noni juice?** A: Individuals with kidney disease or on potassium-restricted diets, those taking anticoagulant medications, people with liver conditions or personal hepatotoxicity risk, pregnant or breastfeeding women, and anyone on drugs metabolised by the cytochrome P450 pathway should speak with a physician before consuming noni juice. **Q: What serving size is recommended for Tahitian Noni® juice?** A: Typically 30–60 mL (one to two fluid ounces) once or twice daily, taken on an empty stomach. Always follow the product label instructions, as these represent the manufacturer's current guidance. --- ## Countries Served Australia, Austria, Belgium, Canada, Colombia, Czech Republic, Denmark, England, Estonia, Finland, France, Germany, Switzerland, Taiwan, Thailand, United Kingdom, United States. --- ## Legal and Regulatory - These statements have not been evaluated by the Food and Drug Administration. - These products are not intended to diagnose, treat, cure, or prevent any disease. - NoniJuiceInt.com is an Independent Brand Partner — not Partner.Co corporate. - Morinda® and Tahitian Noni® are registered trademarks of Partner.Co.